☆ 4.5 Letter

Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

NATURE REVIEWS RHEUMATOLOGY (2023)

Journal

NATURE REVIEWS RHEUMATOLOGY

Volume -, Issue -, Pages -

Publisher

NATURE PORTFOLIO

DOI: 10.1038/s41584-023-01014-3

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.